Physician profile
Ronald Guberman
NPI 1689757072
$336,515.41
in general payments reported to CMS, 2019-2025
47 companies · $39K in 2025
The $39K reported for 2025 was more than what 99% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $18K · 2021: $22K · 2022: $63K · 2023: $115K · 2024: $64K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $185K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $14K · Food and Beverage: $9,318 · Travel and Lodging: $8,297 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $184,628.70 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,676.00 |
| Food and Beverage | $9,317.91 |
| Travel and Lodging | $8,297.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,099.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $231,220.56 | 2019-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Kerecis Limited | $26,084.74 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $21,533.94 | 2019-2025 | Collagenase Santyl, Grafix Pl, Iodosorb Ointment 40g USA |
| Royal Biologics, INC. | $17,082.60 | 2021-2023 | |
| Osteomed LLC | $14,588.31 | 2019-2022 | |
| Acumed LLC | $14,062.55 | 2021-2025 | Osteomed, Acumed, Acumed |
| Trilliant Surgical LLC. | $3,761.51 | 2020 | |
| Ossio INC | $1,427.62 | 2020-2023 | |
| Nevro Corp. | $613.44 | 2021-2024 | Senza |
| Organogenesis INC. | $610.14 | 2019-2025 | Apligraf |
| Paratek Pharmaceuticals, INC. | $565.98 | 2020-2025 | Nuzyra |
| Next Science LLC | $526.39 | 2023-2025 | Blastx, Xperience, Surgx |
| Linvatec Corporation | $500.00 | 2024 | Biobrace 23mm |
| Stryker Corporation | $444.37 | 2020-2025 | Citrefix, Limflow System, 7 X 23mm Citrelock Implant |
| Integra Lifesciences Corporation | $313.00 | 2022 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $299.48 | 2024 | |
| Zimmer Biomet Holdings, INC. | $248.09 | 2022-2024 | Tapestry |
| Urgo Medical North America, LLC | $186.56 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Tactile Systems Technology INC | $158.48 | 2022-2025 | Nimbl, Flexitouch Plus |
| Polarityte, INC. | $153.24 | 2019 | |
| Novastep INC. | $146.71 | 2025 | Nexis |
| Lifenet Health | $139.61 | 2025 | Theragenesis Wound Matrix |
| Hydrofera LLC | $130.32 | 2021-2023 | Hydrofera Blue |
| Kuros Biosciences USA, INC | $125.15 | 2022 | |
| Ibsa Pharma INC. | $125.00 | 2023 | Licart |
| Ani Pharmaceuticals, INC. | $125.00 | 2024 | Purified Cortrophin Gel |
| Acell, INC. | $124.32 | 2019 | |
| Cardiovascular Systems INC. | $116.67 | 2019 | |
| Amgen INC. | $110.77 | 2025 | Krystexxa |
| Medtronic Vascular, INC. | $110.73 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $101.56 | 2021 | |
| Biocomposites INC | $94.45 | 2025 | Stimulan |
| Medartis INC. | $92.00 | 2022-2024 | Aptus |
| Kowa Pharmaceuticals America, INC. | $91.12 | 2023 | Seglentis |
| Abbvie INC. | $78.47 | 2021-2025 | |
| Aroa Biosurgery Incorporated | $59.32 | 2020 | |
| Melinta Therapeutics, LLC | $54.63 | 2021 | |
| Orthofix Medical, INC. | $49.95 | 2020 | |
| Djo, LLC | $48.50 | 2022 | |
| Polynovo North America LLC | $40.65 | 2024 | Novosorb Btm |
| Guard Medical INC. | $39.21 | 2025 | Npseal |
| Solventum Corporation | $33.14 | 2025 | Activ.A.C. |
| Bioventus LLC | $23.83 | 2022 | |
| Convatec INC. | $23.72 | 2019 | |
| Kci USA, INC. | $18.98 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $15.37 | 2025 | |
| Hartmann USA, INC. | $15.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$7,250.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Guberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.